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DNA double-strand break (DSB) repair by homolo-
gous recombination (HR) is initiated by CtIP/MRN-
mediated DNA end resection to maintain genome
integrity. SAMHD1 is a dNTP triphosphohydrolase,
which restricts HIV-1 infection, and mutations are
associated with Aicardi-Goutie`res syndrome and
cancer. We show that SAMHD1 has a dNTPase-inde-
pendent function in promoting DNA end resection to
facilitate DSB repair by HR. SAMHD1 deficiency or
Vpx-mediated degradation causes hypersensitivity
to DSB-inducing agents, and SAMHD1 is recruited
to DSBs. SAMHD1 complexes with CtIP via a
conserved C-terminal domain and recruits CtIP to
DSBs to facilitate end resection and HR. Signifi-
cantly, a cancer-associated mutant with impaired
CtIP interaction, but not dNTPase-inactive SAMHD1,
fails to rescue the end resection impairment of
SAMHD1 depletion. Our findings define a dNTPase-
independent function for SAMHD1 in HR-mediated
DSB repair by facilitating CtIP accrual to promote
DNA end resection, providing insight into how
SAMHD1 promotes genome integrity.
INTRODUCTION
DNA double-strand breaks (DSBs) are cytotoxic lesions induced
by exogenous agents, such as ionizing radiation (IR), and endog-
enous sources, such as replication stress and meiotic recombi-
nation. Failure to repair DSBs leads to cell death or mutagenic
events that drive genomic instability. Indeed, DSB repair defects
are associated with cancer, premature aging, neurodegenera-
tion, infertility, and developmental and immunological abnormal-
ities (Jackson and Bartek, 2009). DSBs are repaired predomi-
nantly by two distinct, but highly coordinated pathways:Cell Re
This is an open access article under the CC BY-Nerror-prone non-homologous end joining (NHEJ), which involves
direct ligation of broken DNA ends and error-free homologous
recombination (HR), which involves an intact copy of the
damaged site (Symington and Gautier, 2011). Whereas NHEJ
operates throughout the cell cycle, HR functions primarily in
S/G2 phase, when a sister chromatid is available as a repair tem-
plate. HR is initiated by DNA end resection in which processing
of the 50 ends of DSBs by the CtBP-interacting protein (CtIP)
endonuclease (Limbo et al., 2007; Makharashvili et al., 2014;
Sartori et al., 2007; Wang et al., 2014; You et al., 2009), together
with the MRE11-RAD50-NBS1 (MRN) endo and 30 to 50 exonu-
clease complex (Anand et al., 2016; Cannavo and Cejka, 2014;
Garcia et al., 2011; Nicolette et al., 2010; Paull and Gellert,
1998; Stracker and Petrini, 2011), generates short 30 single-
stranded DNA (ssDNA) overhangs, which are further extended
by the EXO1 or DNA2 nucleases together with the BLM or
WRN helicase (Cejka et al., 2010; Gravel et al., 2008; Mimitou
and Symington, 2008; Nimonkar et al., 2011; Niu et al., 2010;
Zhu et al., 2008). The 30 ssDNA overhangs are bound by RPA,
which is then displaced by RAD51 to form a RAD51-ssDNA
nucleoprotein filament with the assistance of mediator proteins,
including BRCA2, to mediate HR (Prakash et al., 2015). RPA-
ssDNA also recruits ATRIP to activate the ATR checkpoint kinase
(Zhang et al., 2016; Zou and Elledge, 2003). Thus, DNA end
resection is a critical determinant of DNA repair pathway choice
and checkpoint activation.
Sterile alpha motif and histidine-aspartic acid (HD) domain-
containing protein 1 (SAMHD1) is a deoxyribonucleoside
triphosphate (dNTP) triphosphohydrolase (Goldstone et al.,
2011; Powell et al., 2011) with a well-defined role in restricting
HIV type 1 (HIV-1) and other viral infections, particularly in
non-dividing cells by depleting dNTPs required for reverse tran-
scription and replication (Baldauf et al., 2012; Hrecka et al., 2011;
Laguette et al., 2011; Lahouassa et al., 2012). Mutations in
SAMHD1 also cause Aicardi-Goutie`res syndrome (AGS) (Rice
et al., 2009), a congenital neurodegenerative autoimmune disor-
der, and, moreover, SAMHD1 is recurrently mutated in chronic
lymphocytic leukemia (CLL) (Clifford et al., 2014), frequentlyports 20, 1921–1935, August 22, 2017 ª 2017 The Author(s). 1921
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mutated in colorectal cancer (Rentoft et al., 2016), as well as
mutated or downregulated in a number of other cancers
(Kohnken et al., 2015), suggesting that SAMHD1 functions as a
tumor suppressor. SAMHD1 contains a SAM domain, a protein
interaction module (Schultz et al., 1997) and a HD domain, found
in a superfamily of proteins with metal-dependent phosphohy-
drolase activity (Aravind and Koonin, 1998). In addition to its
well-established dNTPase activity, SAMHD1 binds to ssDNA/
RNA (Beloglazova et al., 2013; Goncalves et al., 2012; Seamon
et al., 2015, 2016; T€ungler et al., 2013) at its dimer-dimer inter-
face, which sterically blocks tetramerization (Seamon et al.,
2016) required for its dNTPase activity (Brandariz-Nun˜ez et al.,
2013; Hansen et al., 2014; Ji et al., 2014; Yan et al., 2013; Zhu
et al., 2013), and SAMHD1 has been reported to possess
DNase/RNase activity (Beloglazova et al., 2013; Ryoo et al.,
2014), however, a number of studies indicate that SAMHD1 lacks
active-site-associated nuclease activity (Antonucci et al., 2016;
Goldstone et al., 2011; Goncalves et al., 2012; Seamon et al.,
2015, 2016; Welbourn and Strebel, 2016), which has been attrib-
uted to persistent co-purifying contaminants (Antonucci et al.,
2016; Seamon et al., 2015).
SAMHD1 has been shown to promote genome integrity by
maintaining dNTP pool balance through its dNTPase activity
(Franzolin et al., 2013; Kohnken et al., 2015; Kretschmer et al.,
2015; Clifford et al., 2014; Rentoft et al., 2016). Increased spon-
taneous DNA damage and dNTP pools was observed in cells
from AGS patients with SAMHD1 dysregulation (Kretschmer
et al., 2015), and SAMHD1 depletion in cells leads to dNTP
pool imbalance in cycling cells (Franzolin et al., 2013). Moreover,
several heterozygous colorectal cancer-associated mutations
impair SAMHD1’s dNTPase activity, and elevated dNTP pools
in combination with inactivated mismatch repair increase muta-
tion rates, suggesting that heterozygous cancer-associated
SAMHD1 mutations increase mutation rates in cancer cells
(Rentoft et al., 2016). Consistent with these findings, SAMHD1
overexpression in cells causes DNA damage hypersensitivity,
however, somewhat paradoxical to its role in dNTP pool regula-
tion, overexpressed SAMHD1-HA localizes to DNAdamage sites
(Clifford et al., 2014). How SAMHD1 functions to promote
genome integrity is unclear. Here, we show that SAMHD1 has
an unexpected dNTPase-independent function in promoting
DNA end resection to facilitate DSB repair by HR through CtIP
recruitment to DNA damage sites.
RESULTS
SAMHD1 Functions in DNA DSB Repair
To determine the role of SAMHD1 in responding to DNA dam-
age, we examined U2OS cells depleted for SAMHD1 for sensi-
tivity to IR, etoposide, and camptothecin (CPT), which directly
or indirectly induce DSBs. Two small interfering RNAs (siRNAs)
targeting SAMHD1 caused IR, CPT, and etoposide hypersensi-
tivity compared to a non-targeting (NT) control (Figures
1A–1C), implying that SAMHD1 responds to DSBs. Western
blot analysis confirmed SAMHD1 knockdown in these cells
(Figure 1D). A similar CPT hypersensitivity following SAMHD1
depletion was observed in MCF7 cells, which could be rescued
by expression of exogenous SAMHD1-GFP (Figures 1E1922 Cell Reports 20, 1921–1935, August 22, 2017and 1F), non-tumorigenic BEAS-2B cells, (Figures S1A and
S1B), and was also observed in HCT-116 SAMHD1 knockout
(KO) cells (Figures S1C and S1D), suggesting that the pheno-
type is not cell-type specific, is not due to an off-target effect,
and that SAMHD1-GFP is functional for alleviating DSB-
inducing agent sensitivity. To provide direct evidence that
SAMHD1 responds to DSBs at the single-cell level, we per-
formed a neutral comet assay in U2OS cells depleted for
SAMHD1 and treated with IR. SAMHD1 depletion in cells
caused a significant delay in repair of IR-induced DSBs, as
measured by comet tail moment compared to a NT control in
cells synchronized in S phase (Figures 1G, 1H, and S1E), but
not in unsynchronized cells (Figures S1E–S1G), suggesting
that SAMHD1 promotes DSB repair predominantly in S phase,
where HR is dominant.
SAMHD1Localizes to DSBs in Response toDNADamage
Overexpressed SAMHD1-HA has been reported to localize to
DNA damage sites in response to CPT treatment (Clifford
et al., 2014). To determine if endogenous SAMHD1 behaves
similarly and localizes to DSBs, we analyzed SAMHD1 accu-
mulation at DNA damage sites in response to IR and CPT
treatment in HeLa cells. A significant increase in percent of
cells with endogenous SAMHD1 foci was observed following
IR and CPT treatment (Figure 2A), which co-localized with
gH2AX, a marker for DSBs (Figure 2B), and RAD51, a marker
for HR (Figure 2C), suggesting that SAMHD1 localizes directly
to DSBs in response to DNA damage. Both endogenous
SAMHD1 and SAMHD1-GFP expressed in U2OS cells also
localized to DNA damage sites induced by laser microirradia-
tion, which co-localized with RPA70, a marker for ssDNA
formed by DSB end resection (Figures 2D and S2). To deter-
mine if endogenous SAMHD1 localizes to nascent DNA
(naDNA) at CPT-induced one-sided DSBs and rule out co-
localization resulting from random events, we used single-
molecule super-resolution (SR) microscropy (Whelan et al.,
2016) on U2OS cells pulse labeled with EdU and treated with
or without CPT. Similar to CtIP, a significant increase in co-
localization of SAMHD1 with naDNA above random levels
was observed following CPT treatment (Figures 2E and 2F),
suggesting that SAMHD1 localizes directly to replication-asso-
ciated DSBs.
SAMHD1 Functions in DSB Repair by Facilitating HR
Poly ADP-ribose polymerase (PARP) inhibitor sensitivity is asso-
ciated with defects in HR (Helleday et al., 2005). Indeed,
SAMHD1 depletion in U2OS, MCF7, and primary small airway
epithelial cells caused hypersensitivity to veliparib, a PARP inhib-
itor (Figures 3A, 3B, and S3A–S3C), which could be rescued with
expression of exogenous SAMHD1-GFP (Figure 3B), suggesting
that SAMHD1 may function in HR. To more directly determine if
SAMHD1 functions in HR, we examined SAMHD1 depletion in
U2OS cells integrated with a direct repeat (DR)-GFP reporter
substrate in which expression of I-SceI endonuclease generates
a DSB that when repaired by HR restores GFP expression
(Pierce et al., 1999). SAMHD1 depletion caused an impairment
in HR (Figure 3C), suggesting directly that SAMHD1 functions
in HR. Notably, while SAMHD1 depletion in U2OS cells resulted
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Figure 1. SAMHD1 Functions in DNA DSB Repair
(A) U2OS cells transfected with indicated siRNAwere seeded for colony formation, treated with indicated doses of IR, and assayed for surviving colonies 12 days
later. The percent of surviving colonies is shown.
(B and C) U2OS cells transfected with non-targeting (NT) or SAMHD1 siRNA were treated with indicated doses of CPT (B) or etoposide (C) for 72 hr and assayed
for cell viability using Alamar Blue.
(D) Western blot analysis showing SAMHD1 knockdown in U2OS cells at 72 hr.
(E) MCF7 cells transfected with indicated siRNAs and plasmids were treated with 200 nM CPT for 72 hr and assayed for viability with Alamar Blue. The treated to
untreated viability relative to NT siRNA is shown.
(F) Western blot analysis in MCF7 cells demonstrating SAMHD1 knockdown and expression of SAMHD1-GFP.
(G and H) U2OS cells transfected with indicated siRNAs were synchronized bymimosine arrest for 16 hr, released into S phase, and exposed to 10 Gy IR (G). DNA
damage was analyzed by neutral comet assay (H).
(G) Dot plot with median of comet tail moment is shown.
(H) Representative images of comet tails are shown.
(A–C, E, and G) Mean and SEM from at least three independent replicas are shown. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S1.in a 1.5- to 3-fold increase in dNTP pool concentration (Figures
S3D and S3E), we did not observe any significant change in
cell cycle (Figures 3D and 3E), suggesting that the observed
effect is not due to an indirect effect of cell cycle change. Consis-
tent with this finding, SAMHD1 depletion in HeLa cells and non-
tumorigenic BEAS-2B cells impaired RAD51, but not gH2AX foci
accumulation in response to CPT and IR treatment (Figures3F–3H, S3F, and S3G), indicating that SAMHD1 is required for
HR, but not for DSB induction by CPT. In contrast, SAMHD1
depletion in U2OS cells transfected with the pEGFP-Pem1-Ad2
NHEJ reporter substrate (Seluanov et al., 2004) caused no signif-
icant impairment in NHEJ and only a mild increase in NHEJ with
one siRNA (Figures S3H and S3I), implying that SAMHD1 specif-
ically promotes HR, but not NHEJ in DSB repair.Cell Reports 20, 1921–1935, August 22, 2017 1923
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Figure 2. SAMHD1 Localizes to DSBs in Response to DNA Damage
(A–C) HeLa cells were treated with 2 mM CPT for 4 hr, fixed, and processed for immunofluorescence with indicated antibodies.
(A) Percent cells with SAMHD1 foci are shown.
(B and C) Representative immunofluorescence images of SAMHD1 co-localizing with gH2AX (B) or RAD51 (C) after DNA damage are shown.
(D) U2OS cells expressing SAMHD1-GFP were microirradiated, fixed after 1 min, and processed for immunofluorescence with anti-RPA70 antibodies.
(E and F) U2OS cells were treated with 0.1 mM CPT and 10 mM EdU for 1 hr, washed, and processed 1 hr for immunofluorescence with click chemistry and
anti-SAMHD1 and CtIP antibodies. Quantitation (E) and representative SR images (F) of co-localization between nascent DNA (naDNA via EdU) and SAMHD1 or
CtIP showing increased association upon CPT damage are shown.
(A and E) Mean and SEM from at least three independent replicas are shown. ***p < 0.001 and ****p < 0.0001. See also Figure S2.SAMHD1 Facilitates HR and ATR Activation by
Promoting DNA End Resection
HR is initiated by DNA end resection. Thus, we examined for
RPA32 phosphorylation at Ser4/8, a marker for DNA end resec-
tion following CPT treatment. SAMHD1 depletion in U2OS cells
impaired RPA32 Ser4/8 phosphorylation, but not total RPA32
levels in response to CPT (Figure 4A). Consistent with these1924 Cell Reports 20, 1921–1935, August 22, 2017findings, SAMHD1 depletion and KO in U2OS, BEAS-2B, and
primary small airway epithelial cells caused a significant
decrease in RPA70 foci formation in response to CPT and IR (Fig-
ures 4B, 4C, S4A–S4D, and S4F–S4I) and moreover impaired
GFP-RPA70 recruitment to DNA damage sites induced by laser
microirradiation (Figures 4D and S4E). ATRIP localization to DNA
damage sites is dependent on its interaction with RPA-ssDNA. In
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Figure 3. SAMHD1 Functions in DSB Repair by Facilitating HR
(A) U2OS cells transfected with NT or SAMHD1 siRNAwere treated with indicated doses of veliparib and assayed for surviving colonies 12 days later. The percent
of surviving colonies is shown.
(B) MCF7 cells transfected with indicated siRNAs and plasmids were treated with 50 mM veliparib for 72 hr and assayed for viability with Alamar Blue. The treated
to untreated viability relative to NT siRNA is shown.
(C) U2OS cells integrated with a DR-GFP HR reporter substrate were transfected with indicated siRNAs and I-SceI, fixed, and analyzed for HR by GFP expression
using flow cytometry.
(D) Cell cycle profile of U2OS cells depleted for SAMHD1 was determined by flow cytometry.
(E) Quantitation of cell cycle profile shown.
(F and G) HeLa cells transfected with SAMHD1 or NT siRNA were treated with 2 mM CPT for 4 hr, fixed, and processed for immunofluorescence with indicated
antibodies. Representative images (F) and quantitation (G) of relative percent gH2AX-positive cells with RAD51 foci are shown.
(H) Western blot analysis showing SAMHD1 knockdown in HeLa cells at 72 hr.
(A–C, E, and G) Mean and SEM from at least three replicas are shown. **p < 0.01 and ***p < 0.001. See also Figure S3.this regard, SAMHD1depletion in cells also impaired GFP-ATRIP
foci accumulation in response to CPT (Figures 4E and 4F). More-
over, SAMHD1 depletion in cells impaired CPT-induced ATR
autophosphorylation at Thr-1989, but not total ATR levels (Fig-
ure 4G), suggesting that SAMHD1 is required for efficient ATR
activation following CPT treatment. To more directly determine
the role of SAMHD1 in DNA end resection, we labeled U2OS
cells with BrdU, treated the cells with CPT, and probed the cells
for BrdU exposure under non-denaturing conditions, which
labels ssDNA. SAMHD1 depletion also impaired BrdU foci under
these conditions (Figures 4H and 4I), providing direct support for
SAMHD1 in promoting DNA end resection. Importantly, given its
role as a dNTPase, SAMHD1 depletion in these cells caused only
a mild, but insignificant, impairment in BrdU incorporation underdenaturing conditions (Figure S4J) and to a much lesser extent
than impairment in CPT-induced BrdU foci (cf. Figure 4I). Taken
together, these data strongly suggest that SAMHD1 facilitates
HR and ATR activation by promoting DNA end resection.
SAMHD1 Promotes HR and DNA End Resection
Independent of Its dNTPase Activity
SAMHD1 has been proposed to maintain genome integrity by
regulating dNTP pools. To determine if SAMHD1 dNTPase activ-
ity is required for DSB repair, we performed rescue experiments
with SAMHD1-RFP H206A/D207A, which disrupts SAMHD1’s
active site and impairs its dNTPase activity (Goldstone et al.,
2011; Laguette et al., 2011) and reported DNase/RNase activ-
ities (Beloglazova et al., 2013). Both SAMHD1-RFP wild-typeCell Reports 20, 1921–1935, August 22, 2017 1925
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(WT) and H206A/D207A restored the HR impairment of SAMHD1
depletion in U2OS cells (Figures 5A, 5B, and S5A), suggesting
that SAMHD1’s role in promoting HR is independent of its
dNTPase activity. SAMHD1-HA WT and H206A/D207A also
alleviated the IR-induced RPA70 foci impairment of SAMHD1
depletion in U2OS cells (Figure 5C), suggesting that SAMHD1
promotes DNA end resection independent of its dNTPase
activity.
SAMHD1 Interacts in a Complex with CtIP in Response
to DNA Damage
Because our findings suggest that SAMHD1 facilitates HR by
promoting DNA end resection and its role in HR is independent
of its active-site catalytic activity, we determined whether
SAMHD1 might function with other nucleases. Co-immunopre-
cipitation (coIP) of SAMHD1-HA expressed in 293T cells pulled
down GFP-CtIP and endogenous MRE11 (Figure 5D), and, simi-
larly, coIP of CtIP-FLAG pulled down SAMHD1-RFP in response
to IR (Figure 5E), suggesting that SAMHD1 interacts with CtIP
and MRE11 in a damage-regulated manner. We validated that
endogenous SAMHD1 coIPs with endogenous CtIP in response
to IR (Figure 5F), and that endogenous SAMHD1 coIPswith GFP-
MRE11 in response to IR (Figure S5B). The coIP of endogenous
SAMHD1 with CtIP and MRE11 following IR was preserved even
following benzonase nuclease treatment (Figure S5C), suggest-
ing that the damage-regulated interaction of SAMHD1 with CtIP
and MRE11 is not mediated through DNA. Moreover, bacterially
recombinant SAMHD1 pulled down recombinant GST-CtIP (Fig-
ure 5G), suggesting that SAMHD1 binds directly to CtIP. To iden-
tify the region of SAMHD1 that interacts with CtIP, we generated
SAMHD1 deletion mutants and performed coIP of SAMHD1 WT
and mutants with GFP-CtIP expressed in 293T cells. In contrast
to SAMHD1-HA (1–115), SAMHD1-HA (115–562) coIP’d with
GFP-CtIP (Figures 5H and 5J), suggesting that the HD, but not
SAM, domain region of SAMHD1 is sufficient for CtIP interaction.
In further mapping experiments, SAMHD1-HA (1–562), but not
SAMHD1 (1–465), coIP’d with GFP-CtIP expressed in 293T cells
(Figures 5I and 5J), suggesting that SAMHD1 amino acids (aa)
465–562 are necessary for interaction with CtIP. To provide
insight into the binding surface of the CtIP interaction domain
of SAMHD1, we examined the crystal structure of tetrameric
SAMHD1 (Ji et al., 2013) and observed that aa 465–562 are
located on the surface of tetrameric SAMHD1 (Figure S5D). Inter-
estingly, a naturally occurring cancer-associated SAMHD1Figure 4. SAMHD1 Facilitates HR and ATR Activation by Promoting DN
(A) U2OS cells transfected with SAMHD1 or NT siRNA were treated with 2 mMCP
(B and C) U2OS cells transfected with SAMHD1 or NT siRNA were treated with 2
antibodies. Representative images (B) and quantitation (C) of relative percent gH
(D) Representative images of GFP-RPA70-expressing U2OS cells transfected wi
damage, and processed for immunofluorescence with anti-gH2AX antibodies.
(E and F) U2OS cells stably transfected with GFP-ATRIP were treated with 2 mM
antibodies. Representative images (E) and quantitation (F) of relative percent gH
(G) HCT-116 cells transfected with SAMHD1 or NT siRNA were treated with 2 mM
bodies.
(H and I) SAMHD1 depleted U2OS cells were treated with 30 mMBrdU for 36 hr, f
conditions and processed for immunofluorescence using anti-BrdU (ssDNA) and
percent gH2AX-positive cells with BrdU foci are shown.
(C, F, and I) Mean and SEM from three independent replicas are shown. ***p < 0mutation (K484T) from a patient with gastric cancer reported in
The Cancer Genome Atlas (TCGA) through the cBioPortal for
Cancer Genomics (Cerami et al., 2012) is located in this region
facing the outside of tetrameric SAMHD1 (Figure S5D) and is
evolutionarily conserved (Figure 5J). While SAMHD1-GFP
K484T overexpressed in cells showed no significant impairment
in dNTPase activity compared with SAMHD1-GFP WT (Figures
S5E and S5F), SAMHD1-HA K484T showed an impairment in
coIPwithGFP-CtIP comparedwith SAMHD1-HAWT (Figure 5K),
suggesting that K484 is critical for SAMHD1’s interaction with
CtIP, but not dNTPase activity, and that a cancer-associated
SAMHD1 mutation is functionally significant in impairing the
interaction of SAMHD1 with CtIP.
SAMHD1 Recruits CtIP to DNA Damage Sites and
Chromatin in Response to DNA Damage and Promotes
DNA End Resection through Its Interaction with CtIP
The damage-regulated interaction of SAMHD1 and CtIP sug-
gests that they may function together to promote DNA end
resection. Consistent with this finding, a significant increase in
co-localization of SAMHD1 with CtIP was observed following
CPT treatment (Figures 6A and 6B). To determine if SAMHD1
cooperates with CtIP in promoting HR and DNA end resection,
we performed epistasis experiments using the DR-GFP reporter
assay and CPT-induced RPA70 foci as readouts. Combined
depletion of SAMHD1 and CtIP did not result in a significantly
greater HR defect or CPT-induced RPA70 foci impairment
compared with their depletion alone (Figures 6C and 6D), sug-
gesting that SAMDH1 cooperates with CtIP in promoting DNA
end resection to facilitate DSB repair by HR. To determine if
SAMHD1 functions upstream of CtIP or MRE11, we evaluated
the recruitment of GFP-CtIP and GFP-MRE11 to DNA damage
sites. SAMHD1 depletion and KO in U2OS cells impaired GFP-
CtIP, but not GFP-MRE11 or gH2AX localization to DNA damage
sites induced by laser microirradiation (Figures 6E and S6), sug-
gesting that SAMHD1 facilitates CtIP, but not MRE11, recruit-
ment to DNA DSBs. Consistent with these findings, SAMHD1
depletion in HCT-116 cells impaired the mobilization of endoge-
nous CtIP to chromatin in response to IR (Figure 6F). To deter-
mine if SAMHD1’s interaction with CtIP is required for its role
in DNA end resection, we performed rescue experiments with
SAMHD1 K484T. In contrast to SAMHD1 H206A/D207A, which
is proficient in HR and DNA end resection (Figures 5A and 5C),
SAMHD1-RFP/GFP K484T failed to rescue the damage-inducedA End Resection
T for 4 hr, harvested, run on SDS-PAGE, and probed with indicated antibodies.
mM CPT for 4 hr, fixed, and processed for immunofluorescence with indicated
2AX-positive cells with RPA70 foci are shown.
th NT or SAMHD1 siRNA, subjected to laser microirradiation, fixed 5 min after
CPT for 4 hr, fixed, and processed for immunofluorescence with anti-gH2AX
2AX-positive cells with GFP-ATRIP foci are shown.
CPT for 4 hr, harvested, run on SDS-PAGE, and probed with indicated anti-
ollowed by 3 mMCPT treatment for 4 hr. Cells were fixed under non-denaturing
gH2AX antibodies. Representative images (H) and quantitation (I) of relative
.001. See also Figure S4.
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CtIP recruitment, IR-induced RPA70 foci impairment, and CPT
hypersensitivity of SAMHD1 deficiency in U2OS cells (Figures
6G–6J), suggesting that SAMHD1 promotes DNA end resection
through its interaction with CtIP, and that this is impaired by a
naturally occurring cancer-associated SAMHD1 mutation.
Collectively, these results imply that SAMHD1 recruits CtIP to
DSBs to facilitate DNA end resection and HR.
Targeting SAMHD1 with Virus-like Particles Containing
Vpx Sensitizes Cancer Cells to DSB-Inducing Agents
SAMHD1 is targeted for proteasomal degradation by the retro-
virus accessory protein Vpx (Hrecka et al., 2011; Laguette
et al., 2011), and virus-like particles (VLPs) containing Vpx
have been used to sensitize acute myelogenous leukemia cells
to cytarabine chemotherapy (Herold et al., 2017; Hollenbaugh
et al., 2017; Schneider et al., 2017). U2OS cells treated with
VLPs containing Vpx showed reduced SAMHD1 protein levels
compared with cells treated with VLPs containing no Vpx (Fig-
ure 7A). Similar to cancer cells with SAMHD1 deficiency by
genetic knockdown or KO, U2OS cells treated with VLPs con-
taining Vpx showed hypersensitivity to CPT and veliparib
compared to control cells (Figures 7B and 7C). Moreover, the
CPT hypersensitivity of U2OS cells treated with VLPs containing
Vpx was alleviated by overexpression of SAMHD1-GFP (Figures
7D and 7E), implying that the effects are mediated specifically
through SAMHD1 degradation. Collectively, these data suggest
that targeting SAMHD1 with VLPs containing Vpx sensitizes
cancer cells to DSB-inducing agents and may be a promising
therapeutic strategy for cancer treatment.
DISCUSSION
Our findings reveal a dNTPase-independent function for
SAMHD1 in promoting HR-mediated DSB repair by facilitating
DNA end resection through CtIP accrual, demonstrating that
SAMHD1 has a direct role in genome maintenance independent
of its role in dNTP pool regulation, establishing SAMHD1 as a
critical regulator of DNA end resection in promoting DSB repairFigure 5. SAMHD1 Promotes HR and DNA End Resection Independent
Damage
(A) U2OS cells integrated with a DR-GFP HR reporter substrate were transfected
gated and analyzed for HR by GFP expression using flow cytometry.
(B) Western blot analysis in U2OS cells demonstrating SAMHD1 knockdown and
(C) U2OS cells were transfected with indicated siRNAs and cDNA, treated with
antibodies. Quantitation of percent gH2AX-positive cells with RPA70 foci that ar
(D) 293T cells were transfected with GFP-CtIP and SAMHD1-HA, treated with 10 G
immunoblotted with indicated antibodies.
(E) 293T cells were transfected with CtIP-FLAG and SAMHD1-RFP, treated with 10
and immunoblotted with indicated antibodies.
(F) Endogenous SAMHD1 was IP’d from lysate from HCT-116 cells treated wit
indicated antibodies.
(G) Recombinant GST-CtIP and SAMHD1 purified from E. coli was pulled dow
immunoblotted with indicated antibodies.
(H and I) 293T cells were transfected with full-length or truncated SAMHD1-HA W
antibodies, run on SDS-PAGE, and immunoblotted with indicated antibodies. Do
with CtIP (H) and aa 465–562 are necessary for interaction with CtIP (I).
(J) Schematic representation of SAMHD1 structural domains and evolutionary co
(K) A naturally occurring cancer-associated SAMHD1 mutation (K484T) impairs t
(A and C) Mean and SEM from three independent replicas are shown. **p < 0.01byHR and identifying theCtIP/MRE11 nucleases as unique inter-
acting partners for SAMHD1. In this regard, we found that
SAMHD1 deficiency by genetic knockdown or KO or proteaso-
mal degradation by VLPs containing Vpx in cells causes IR,
CPT, and etoposide hypersensitivity, and SAMHD1 is recruited
to DSBs that co-localize with gH2AX, RAD51, RPA70, and
naDNA in response to DNA damage. SAMHD1 depletion further
causes PARP inhibitor sensitivity, impaired RAD51 recruitment
to foci, and impaired HR, but not NHEJ, through direct reporter
assays. Moreover, SAMHD1 depletion impairs BrdU exposure,
RPA Ser4/8 phosphorylation, and RPA recruitment to DSBs,
suggesting that SAMDH1 facilitates DNA end resection.
SAMHD1 depletion also impairs CPT-induced ATRIP foci accu-
mulation and ATR autophosphorylation, suggesting that
SAMHD1 is required for efficient ATR activation following CPT
treatment. Mechanistically, SAMHD1 interacts directly with
CtIP via an evolutionarily conserved domain in its C terminus,
which is disrupted by a naturally occurring cancer-associated
SAMHD1mutation, and MRE11 in a damage-regulated manner,
and is required for CtIP, but not MRE11, recruitment to DNA
damage sites. In contrast to dNTPase-inactive SAMHD1, which
is proficient for HR and DNA end resection, the cancer-associ-
ated SAMHD1 mutant with impaired CtIP interaction and profi-
cient dNTPase activity fails to rescue the damage-induced
CtIP recruitment deficit, IR-induced RPA70 foci impairment,
and CPT hypersensitivity of SAMHD1 deficiency. Thus, our find-
ings support a model in which SAMHD1 promotes DSB repair by
HR independent of its well-established dNTPase activity by facil-
itating CtIP recruitment, which in turn cooperates with MRN to
promote DNA end resection (Figure 7F).
SAMHD1 has been reported to possess nuclease activity
(Beloglazova et al., 2013; Ryoo et al., 2014), which has since
been attributed to persistent co-purifying contaminants (Anto-
nucci et al., 2016; Seamon et al., 2015). Our finding of a rescue
of the HR and DNA end resection impairment of SAMHD1 deple-
tion with an active-site mutant of SAMHD1, which abolishes its
dNTPase activity and reported nuclease activity, and interaction
of SAMHD1 with CtIP/MRE11, which are known nucleases,of Its dNTPase Activity and Complexes with CtIP in Response to DNA
with indicated siRNAs, cDNAs, and I-SceI and fixed. RFP-positive cells were
expression of SAMHD1-RFP.
10 Gy IR, and processed 4 hr later for immunofluorescence with indicated
e HA-SAMHD1 positive for complemented cells is shown.
y IR, harvested 4 hr later, IP’d with anti-HA antibodies, run on SDS-PAGE, and
Gy IR, harvested 4 hr later, IP’d with anti-FLAG antibodies, run on SDS-PAGE,
h or without IR, washed, separated by SDS-PAGE, and immunoblotted with
n with an anti-SAMHD1 antibody, washed, separated by SDS-PAGE, and
T and GFP-CtIP, treated with 10 Gy, IR, harvested 4 hr later, IP’d with anti-HA
main mapping analysis indicates that aa 115–562 are sufficient for interaction
nservation of CtIP interaction domain.
he interaction of SAMHD1 with CtIP.
and ***p < 0.001. See also Figure S5.
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Figure 6. SAMHD1 Recruits CtIP to DNA Damage Sites and Chromatin in Response to DNA Damage and Promotes DNA End Resection
through Its Interaction with CtIP
(A and B) U2OS cells were treated with 0.1 mM CPT and 10 mM EdU for 1 hr, washed, and processed 1 hr for immunofluorescence with click chemistry and
anti-SAMHD1 and CtIP antibodies.
(A) Quantitation of co-localization of SAMHD1 and CtIP upon CPT damage.
(legend continued on next page)
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suggest that SAMHD1’s role in promoting DNA end resection is
likely independent of any intrinsic catalytic activity and thus
through a scaffold function. In this respect, SAMHD1 localizes
to naDNA at CPT-induced DSBs and binds to ssDNA/RNA
(Beloglazova et al., 2013; Goncalves et al., 2012; Seamon
et al., 2015, 2016; T€ungler et al., 2013) and could facilitate CtIP
recruitment to or stabilization at DSBs through this interaction.
CtIP recruitment to DNA damage sites is also dependent on its
interaction with the MRN complex (You et al., 2009; Yuan and
Chen, 2009), BRCA1 (Yu et al., 2006), and its own tetramerization
(Wang et al., 2012), which could be regulated by SAMHD1.
Given SAMHD1’s well-established role as a dNTPase, how
might this activity be reconciled with its role in promoting DNA
end resection and HR? SAMHD1 binds to ssDNA at its dimer-
dimer interface, which sterically blocks its tetramerization into
its dNTPase active form (Brandariz-Nun˜ez et al., 2013; Hansen
et al., 2014; Ji et al., 2014; Seamon et al., 2016; Yan et al.,
2013; Zhu et al., 2013). Thus, SAMHD1 may function as a mono-
mer or dimer in promoting DNA end resection and tetramer
in promoting dNTPmetabolism, which is controlled by its binding
to ssDNA in response to DNA DSB induction. This may explain,
at least in part, why SAMHD1 overexpression, which may
facilitate its tetramerization, does not fully rescue the CPT hyper-
sensitivity of SAMHD1 deficiency. Our finding that SAMHD1
promotes DNA end resection provides further support for a com-
mon role in nucleic acid metabolism that is shared by SAMHD1
and other AGS susceptibility proteins TREX1, RNaseH2, and
ADAR1, suggesting that SAMHD1’s role in DNA DSB repair
may be important for preventing improper innate immune
response and autoimmune disease.
A role for SAMHD1 in maintaining genome integrity and pre-
venting cancer has previously been attributed to its activity in
dNTP pool regulation (Clifford et al., 2014; Franzolin et al.,
2013; Kohnken et al., 2015; Kretschmer et al., 2015; Rentoft
et al., 2016). Our findings now demonstrate that SAMHD1 also
has a direct role in genome maintenance by promoting DNA
end resection to facilitate DSB repair by HR independent of its
canonical role in dNTP metabolism. Given that SAMHD1 is
dysregulated in a number of cancers, SAMHD1’s role in DSB
repair may help explain, at least in part, how its dysregulation(B) Representative SR images of a single foci showing SAMHD1/CtIP co-localiza
(C) U2OS cells integrated with a DR-GFP HR reporter substrate were transfected w
using flow cytometry.
(D) U2OS cells transfected with CtIP, SAMHD1, or NT siRNA were treated with 2
antibodies. Quantitation of relative percent gH2AX-positive cells with RPA70 foc
(E) Representative images of GFP-CtIP-expressing U2OS cells transfected with
damage, and processed for immunofluorescence with anti-gH2AX antibodies.
(F) HCT-116 cells transfected with SAMHD1 or NT siRNA were treated with 10 G
proteins were run on SDS-PAGE and immunoblotted with indicated antibodies.
(G) Representative images of U2OS SAMHD1 WT and KO cells expressing RFP-
damage, and processed for immunofluorescence with anti-gH2AX antibodies.
(H) U2OS cells were transfected with indicated siRNAs and cDNA, treated with
RPA70, HA, and gH2AX antibodies. Quantitation of percent gH2AX-positive cells
three independent replicas of 60 cells counted each is shown.
(I) U2OS cells transfected with indicated siRNAs and plasmids were treated with 2
to untreated viability relative to NT siRNA is shown.
(J) Western blot analysis showing expression of SAMHD1-GFP and endogenous
transfection. The higher levels of SAMHD1 in the SAMHD1-GFP-transfected cell
(A, C, D, H, and I) Mean and SEM from three independent replicas are shown. **is associated with genomic instability and carcinogenesis.
Indeed, our findings show that a naturally occurring gastric can-
cer-associated SAMHD1 mutation impairs the interaction of
SAMHD1 with CtIP, but not its dNTPase activity, and the mutant
SAMHD1 fails to rescue the CtIP recruitment deficit, DNA end
resection impairment, and CPT hypersensitivity of SAMHD1
deficiency, suggesting that SAMHD1’s interaction with CtIP
may be important for the prevention of genomic instability and
cancer. As several heterozygous colorectal cancer-associated
mutations impair SAMHD1’s dNTPase activity, and increased
dNTP levels contribute to mutagenesis (Rentoft et al., 2016),
collectively, these findings support a role for SAMHD1 in main-
taining genome integrity and preventing cancer through dual
roles in DNA end resection and dNTP metabolism.
As our data suggest that SAMHD1 plays a critical role in the
response of cancer cells to DSB-inducing agents, SAMHD1
may also be a promising therapeutic target for cancer therapies
that induce DSBs. Our finding that targeting SAMHD1 for protea-
somal degradation with VLPs containing Vpx sensitizes cancer
cells to DSB-inducing agents provides rationale for the use of
VLPs containing Vpx in augmenting the efficacy of IR, PARP
inhibitor, and other DSB-inducing agents as a potential
approach for cancer therapy. Another rationale-driven approach
for cancer therapy based on our work will be to disrupt the inter-
action of SAMHD1 and CtIP with small molecule inhibitors to be
used as an adjunct to DSB-inducing agents.
EXPERIMENTAL PROCEDURES
Cell Culture, Plasmids, and siRNA
293T, HeLa, HCT-116, MCF7, and U2OS cells were grown in DMEM (GIBCO),
supplemented with 7.5% fetal bovine serum (FBS). Stably transfected cells
were maintained with 1 mg/mL puromycin (Fisher). SAMHD1-GFP/RFP plas-
mids were generated by cloning SAMHD1 in pcDNA3.1-GFP/RFP (Addgene,
# 70219 or 13032, respectively) using EcoRI/BamHI restriction sites. SAMHD1
WT and truncations were cloned in pKH3 (Addgene, # 12555) using EagI and
XbaI to generate SAMHD1-HA. GFP-CtIP, FLAG-CtIP, and GFP-FLAG-
MRE11 plasmids were obtained from Dr. Steve Jackson (Sartori et al., 2007;
Schmidt et al., 2015). GFP-RPA70 plasmid was obtained from Dr. Marc
Wold (Haring et al., 2008). ATRIP-GFP plasmid was obtained from Dr. Akira
Matsuura (Itakura et al., 2005). Plasmid transfections were performed using
Lipofectamine 2000 (Invitrogen), following manufacture’s instruction. Cellstion in cells also labeled for naDNA.
ith indicated siRNAs and I-SceI, fixed, and analyzed for HR by GFP expression
mM CPT for 4 hr, fixed, and processed for immunofluorescence with indicated
i is shown.
NT or SAMHD1 siRNA, subjected to laser microirradiation, fixed 5 min after
y IR and harvested 1 hr later for biochemical fractionation. Chromatin bound
NS indicates non-specific band as loading control.
SAMHD1 and GFP-CtIP, subjected to laser microirradiation, fixed 5 min after
10 Gy IR, and processed 4 hr later for indirect immunofluorescence with anti-
with RPA70 foci that are SAMHD1-GFP-positive for complemented cells, from
00 nMCPT for 72 hr prior to assaying for viability with Alamar Blue. The treated
SAMHD1 in U2OS cells 72 hr after siRNA transfection and 48 hr after cDNA
s likely represent exogenous SAMHD1 cleaved from SAMHD-GFP.
p < 0.01 and ****p < 0.0001. See also Figure S6.
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Figure 7. Targeting SAMHD1 with Virus-like Particles Containing Vpx Sensitizes Cancer Cells to DSB-Inducing Agents
(A) Western blot analysis showing SAMHD1 degradation in U2OS cells treated with VLPs containing Vpx or no Vpx for 48 hr.
(B and C) U2OS cells were treated with VLPs containing Vpx or no Vpx for 48 hr, followed by indicated doses of CPT (B) or veliparib (C) for 72 hr and assayed for
cell viability using Alamar Blue.
(D) U2OS cells transfected with or without SAMHD-GFP were treated with VLPs containing Vpx or no Vpx for 48 hr followed by 50 nM CPT for 72 hr and assayed
for cell viability using Alamar Blue.
(E) Western blot analysis showing expression of SAMHD1-GFP and endogenous SAMHD1 in U2OS cells 72 hr after transfection and 48 hr after treatment with
VLPs containing Vpx or no Vpx, at which time cells were treated as in (D). The higher levels of SAMHD1 in the SAMHD1-GFP-transfected and Vpx-treated cells
(lower band in third lane) likely results from a combination of endogenous SAMHD1 and exogenous SAMHD1 cleaved from SAMHD-GFP that has not been
degraded.
(F) Model showing SAMHD1 function in DNA end resection to facilitate DSB repair by HR. In response to DSB-inducing agents, SAMHD1 interacts with CtIP/MRN
in a damage-regulated manner and recruits CtIP to DSBs to promote DNA end resection, facilitating DSB repair by HR.
(B–D) Mean and SEM from three independent replicas are shown. **p < 0.01 and ***p < 0.001.were transfected with siRNA using Lipofectamine RNAi Max (Invitrogen),
following the manufacturer’s instructions. siRNAs were purchased from Dhar-
macon or QIAGEN.
Immunoblot
Cells were harvested in PBS and lysed for 30 min on ice in IP lysis buffer
(200 mM NaCl, 0.75% Chaps, and 50 mM Tris pH 8.0) or radioimmunoprecipi-
tation assay (RIPA) buffer (10 mM Tris-Cl [pH 8.0], 1 mM EDTA, 1% Triton
X-100, 0.1% sodium deoxycholate, 0.1% SDS, and 140 mM NaCl) (Hall
et al., 2014), supplemented with protease inhibitors. Lysates were clarified
by centrifugation (13,000 rpm for 10 min at 4C) and the supernatants were
collected. Protein samples were quantified with the Bradford assay and
resolved by SDS-PAGE, transferred onto polyvinylidene fluoride (PVDF), and
probed using the indicated primary antibodies. The membrane was stained
with Alexa Fluor 680 or 800 anti-mouse/rabbit secondary antibody (Life Tech-
nologies) and visualized with the LI-COR Odyssey system. The following anti-
bodies were used for staining: GAPDH (Santa Cruz, sc-47724); FLAG (Santa1932 Cell Reports 20, 1921–1935, August 22, 2017Cruz, sc-51590); GFP (Abcam, Ab6556); HA (Sigma, H9658), RPA70
(Cell Signal, 2267), RPA32 (Santa Cruz, sc-14692), SAMHD1 (OriGene,
TA502024), CtIP (14-1, a generous gift from Richard Baer) (Yu and Baer,
2000), BRCA2, RAD51 (Calbiochem, PC130), gH2AX (Cell Signal, 2577 orMilli-
pore, 05-636), 53BP1 (Bethyl Labs, A300-273A), BrdU (BD Biosciences,
347580), and MRE11 (Abcam, ab30725).
Cell Viability Assay
Cell viability assays were performed as previously described (Colbert et al.,
2014; Smith et al., 2014; Yu et al., 2010; Zhang et al., 2013). Briefly, cells
were plated at a density of 53 105 cells/well in 6-well plates and siRNA trans-
fected at 25 nM. 24 hr post knockdown, media were replaced with or without
overexpression solution containing media supplemented with plasmid DNA,
Lipofectamine 2000, and Opti-MEM solution. Cells were treated with VLP con-
taining Vpx or no Vpx, as described previously (Berger et al., 2011; Kim et al.,
2012), with minor modification. 24 hr after initial transfection or transduction
with Vpx VLPs, cells were trypsinized, counted, and replated in triplicate to a
density of 2 3 103 cells/well in 96-well plates. 24 hr after plating, cells were
treated with media containing the drug for 72 hr. Cell viability was then
assessed via Alamar Blue (resazurin) reagent, incubated at 1:10 dilution for
6 hr, and assayed for fluorescence according to the manufacturer’s protocol.
Viability fractionswere normalized to vehicle-treated controls exposed to iden-
tical transfection conditions.
Statistical Analysis
Unless otherwise stated, experiments were performed at least three times and
analyzed using unpaired two-tailed Student’s t test and data expressed as
mean ± SEM, p < 0.05 was considered statistically significant.
IP, Immunofluorescence, Clonogenic Assay, DSB Repair Reporter Assay,
Laser Microirradiation Assay, DNA End Resection, Comet Assay, dNTP Pool
Quantitation, KOCell Generation, Chromatin Fractionation Assay, SR Imaging.
Details of these methodologies can be found in Supplemental Experimental
Procedures.
ACCESSION NUMBERS
The accession number for SAMHD1 crystal structure used to generate a
Figure S5D is RCSB PDB: 4BZB.
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SUPPLEMENTAL DATA ITEMS 
 
 
 
Figure S1 is Related to Figure 1. SAMHD1 Functions in DNA DSB Repair. (A) BEAS-2B cells transfected with 
SAMHD1 or NT siRNA were treated with 800 nM CPT for 72 h prior to assaying for cell viability with 
AlamarBlue. Treated to untreated viability relative to NT siRNA was determined. (B) Western blot analysis showing 
SAMHD1 knockdown in BEAS-2B cells 72 h after transfection. (C) HCT-116 WT and SAMHD1 KO (KO1 and 
KO2) cells were treated with indicated doses of CPT for 72 h and assayed for cell viability using AlamarBlue. (D) 
Western blot analysis of lysate from HCT-116 WT and SAMHD1 KO cells generated by CRISPR/Cas9 with two 
unique guide RNAs (gRNA1 and gRNA2). (E) U2OS cells transfected with indicated siRNAs were synchronized by 
16 h mimosine arrest followed by a 7 h release. DNA content of synchronized and unsynchronized cells was 
analyzed by flow cytometry. (F-G) Unsynchronized U2OS cells transfected with indicated siRNAs were treated 
with or without 10 Gy IR and allowed to recover for the indicated times. DNA damage was analyzed by neutral 
comet assay. (F) Dot plot with median of comet tail moment is shown. *** p < 0.001. (G) Representative images of 
comet tails are shown.  
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Figure S2 is Related to Figure 2. SAMHD1 Localizes to DSBs in Response to DNA Damage. U2OS cells were 
microirradiated with a Photonics 365 nM laser, fixed after 1 min, and processed for indirect immunofluorescence 
with anti-RPA70 and H2AX antibodies.  
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Figure S3 is Related to Figure 3. SAMHD1 Functions in DSB Repair by Facilitating HR. (A) MCF7 cells 
transfected with indicated siRNAs were treated with indicated doses of Veliparib for 72 h and assayed for cell 
viability using AlamarBlue. (B) Primary small airway epithelial cells transfected with SAMHD1 or NT siRNA were 
treated with indicated doses of Veliparib for 72 h and assayed for cell viability using AlamarBlue. (C) Western blot 
analysis showing SAMHD1 knockdown in primary small airway epithelial cells 72 h after transfection. (D) dNTP 
samples extracted from U2OS cells depleted of SAMHD1 were used to perform a RT based primer extension assay 
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to determine dATP, dCTP, dGTP and dTTP concentrations. Shown is representative gel image. (E) Mean and SEM 
of dNTP concentration from three replicas is shown. (F-G) BEAS-2B cells transfected with SAMHD1 or NT siRNA 
were treated with 10 Gy IR, fixed 4 h later, and processed for indirect immunofluorescence with anti-RAD51 and 
H2AX antibodies. (F) Representative images showing impairment in IR-induced RAD51 but not H2AX foci by 
SAMHD1 depletion are shown. (G) Quantitation of relative percent H2AX positive cells with RAD51 foci from 3 
independent replicas of at least 200 cells counted each is shown. (H) U2OS cells were transfected with indicated 
siRNAs and the pEGFP-Pem1-Ad2 NHEJ reporter substrate following I-SceI digestion, fixed, and analyzed for 
NHEJ by GFP expression using flow cytometry. Relative percent NHEJ repair (GFP-positive cells) is shown. (I) 
Western blot analysis showing SAMHD1 knockdown in U2OS cells 72 h after transfection. For (A), (B), (G), and 
(H), mean and SEM from three independent replicas is shown. * p <0.05, ** p < 0.01, *** p < 0.001. 
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Figure S4 is Related to Figure 4. SAMHD1 Facilitates HR by Promoting DNA End Resection. (A) 
Nondamaged U2OS cells transfected with SAMHD1 or NT siRNA were fixed and processed for indirect 
immunofluorescence with anti-RPA70 and H2AX antibodies. Representative images are shown. (B-C) U2OS 
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SAMHD1 WT and KO cells were treated with 10 Gy IR, fixed 4 h later, and processed for indirect 
immunofluorescence with anti-RPA70 and H2AX antibodies. (B) Representative images showing impairment in 
IR-induced RPA70 but not H2AX foci with SAMHD1 knockout is shown. (C) Quantitation of relative percent 
H2AX positive cells with RPA70 foci from 3 independent replicas of 200 cells counted each is shown. (D) Western 
blot analysis of lysate from U2OS WT and SAMHD1 KO cells generated by CRISPR/Cas9. (E) Representative live-
cell images of GFP-RPA70 expressing U2OS cells transfected with NT or SAMHD1 siRNA, subjected to laser 
micro-irradiation, and monitored in real-time by direct immunofluorescence. (F-G) BEAS-2B cells transfected with 
SAMHD1 or NT siRNA were treated with 10 Gy IR, fixed 4 h later, and processed for indirect immunofluorescence 
with anti-RPA70 and H2AX antibodies. (F) Representative images showing impairment in IR-induced RPA70 but 
not H2AX foci with SAMHD1 depletion are presented. (G) Quantitation of relative percent H2AX positive cells 
with RPA70 foci from 3 independent replicas of 200 cells counted each is shown. (H-I) Primary small airway 
epithelial cells transfected with SAMHD1 or NT siRNA were treated with 10 Gy IR, fixed 4 h later, and processed 
for indirect immunofluorescence with anti-RPA70 and H2AX antibodies. (H) Representative images showing 
impairment in IR-induced RPA70 but not H2AX foci with SAMHD1 depletion is shown. (I) Quantitation of 
relative percent H2AX positive cells with RPA70 foci from 3 independent replicas of 200 cells counted each is 
shown. (J) Quantitation of BrdU incorporation under denaturing conditions for SAMHD1 depleted U2OS cells 
treated with 30 µM BrdU for 36 h followed by 3µM CPT treatment for 4 h. Cells were fixed, denatured with HCl, 
and processed for indirect immunofluorescence using anti-BrdU antibodies. Mean and SEM from three replicas is 
shown. A mild but not statistically significant decrease in BrdU uptake between SAMHD1 and NT depletion was 
observed. For (C), (G), (I), and (J), mean and SEM from three independent replicas is shown. *** p < 0.001. 
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Figure S5 is Related to Figure 5. SAMHD1 Promotes DSB Repair by HR Independent of its dNTPase Activity 
and Complexes with CtIP in Response to DNA Damage. (A)  U2OS cells integrated with a DR-GFP HR reporter 
substrate were transfected with indicated siRNAs, cDNAs, and I-SceI, and fixed. RFP positive cells were gated and 
analyzed for HR by GFP expression using flow cytometry. RFP+ cells and RFP+ cells that are GFP+ are gated.  (B) 
Endogenous SAMHD1 was IP’d from lysate from 293T cells transfected with GFP-MRE11 and treated with or 
without IR, washed, separated by SDS-PAGE, and immunoblotted with anti-GFP and SAMHD1 antibodies. (C) 
Endogenous SAMHD1 was IP’d from lysate from HCT-116 cells treated with IR, washed, treated with benzonase 
nuclease, separated by SDS-PAGE, and immunoblotted with anti-CtIP, MRE11, and SAMHD1 antibodies. (D) 
Structural analysis of SAMHD1 CtIP interaction domain highlighted in red color. The tetrameric SAMHD1 protein 
structure (blue, green, purple, and yellow) was obtained from the Structural Bioinformatics (RCSB) Protein Data 
Bank (PDB), specifically structure 4BZB. A close-up of K484, a site of a naturally occurring gastric cancer 
associated SAMHD1 mutation indicates that it is located on the protein surface. (E) dNTP samples extracted from 
U2OS cells overexpressing SAMHD1-GFP WT or K484T were used to perform a RT based primer extension assay 
to determine dATP concentration. Mean and SEM of dATP concentration from three replicas is shown. ** p < 0.01. 
(F) Western blot analysis showing overexpression of SAMHD1-GFP WT and K484T in U2OS cells 72 h after 
transfection at which time dATP concentration was determined in (E).  
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Figure S6 is Related to Figure 6. SAMHD1 Depletion Impairs CtIP but not MRE11 Recruitment to DNA 
Damage Sites. (A) Representative live-cell images of GFP-CtIP expressing U2OS cells transfected with NT or 
SAMHD1 siRNA, subjected to laser micro-irradiation, and monitored in real-time by direct immunofluorescence. 
(B) Representative images of GFP-CtIP expressing U2OS SAMHD1 WT and KO cells subjected to laser micro-
irradiation, fixed 5 minutes after DNA damage, and processed for indirect immunofluorescence with anti-H2AX 
antibodies. (C) Representative live-cell images of GFP-MRE11 expressing U2OS cells transfected with NT or 
SAMHD1 siRNA, subjected to laser micro-irradiation, and monitored in real-time by direct immunofluorescence. 
(C) Representative images of GFP-MRE11 expressing U2OS cells transfected with NT or SAMHD1 siRNA, 
subjected to laser micro-irradiation, fixed 5 minutes after DNA damage, and processed for indirect 
immunofluorescence with anti-H2AX antibodies. 
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
siRNA Sequences 
NT (ATGAACGTGAATTGCTCAATT) 
siCtIP (siCtIp-1 (GCUAAAACAGGAACGAAUC) 
siSAMHD1 #1 (CAACCAGAGCUGCAGAUAA) 
siSAMHD1 #2 (GAUUCAUUGUGGCCAUAUAA) 
siSAMHD1 5’ UTR (ACGCAUGCUGAAGCTAAGTAA) 
siBRCA2 (GAGACACAAUUACAACUAAA) 
siBRCA1 (CAGCAGUUUAUUACUCACUAA). 
 
Immunoprecipitation 
Cells were harvested in PBS and lysed in IP lysis buffer (0.75% CHAPS, 10% glycerol, 150 mM NaCl, 50 
mM Tris pH 7.5) freshly supplemented with protease inhibitors. Lysates were centrifuged for 15 minutes at 
maximum speed. Supernatants were then collected, diluted by same volume of IP buffer with no CHAPS to adjust 
the CHAPS concentration to 0.375% and protein concentration was determined. Approximately 3-4 mg of protein 
were used for IP. Over expressed proteins with HA, Flag, or GFP/RFP tag were IP’d using HA agarose beads 
(Sigma), FLAG M2 affinity beads (Sigma), or GFP antibody (Abcam; Ab6556) and protein A agarose beads 
(Invitrogen) respectively, while indicated specific antibody combined with IgG was used for endogenous IP. 
Complexes were washed 4 times with IP buffer containing 0.375% CHAPS and protease inhibitors. IP with normal 
rabbit IgG or from cells that do not express epitope-tagged protein were used as negative controls. Protein/bead 
complex was boiled in the presence of SDS loading dye and separated by centrifugation. Supernatant containing 
IP’d proteins was resolved using SDS page gel as described under Immunoblot section. 
 
Binding Assay 
GST-tagged full length SAMHD1, containing a PreScission Protease site, was expressed in E. coli and 
purified using glutathione-Sepharose as described previously (Hollenbaugh et al., 2017). GST tag was removed post 
purification by incubating with precision protease. GST-tagged CtIP was purchased from Novus. Recombinant 
proteins (GST-CtIP + no SAMHD1, or GST-CtIP + SAMHD1) were precleared with protein A agarose beads 
(Invitrogen). The complex was washed and incubated overnight with anti-SAMHD1 antibody (Origene, TA502024) 
and protein A beads (Invitrogen) in IP buffer with .375% Chaps, described above. The beads were washed with IP 
buffer, boiled in presence of SDS loading dye and resolved on SDS page gel as described under Immunoblot 
section. The interacting profile was visualized after staining with anti-SAMHD1 and CtIP antibodies (kind gift from 
Dr. Richard Bear) 
 
Immunofluorescence Analysis 
U2OS, HeLa, BEAS-2B, or small airway epithelial cells were seeded on coverslips were treated with 3 µM 
CPT or 10 Gy of IR. After the indicated recovery time, cells were fixed with 4% (wt/vol) paraformaldehyde (EMD 
Chemicals) for 10 minutes at room temperature, permeabilized with 0.5% Triton X-100 (Fisher Scientific) for 10 
minutes, and then blocked with 5% BSA in PBS. Cells were immunostained with indicated primary antibody diluted 
in 1% BSA, followed by Alexa Fluor 488, 555, or 647 anti-rabbit/mouse secondary antibody (Life technology) 
diluted in 1% BSA in PBS. Coverslips were mounted with DAPI Fluoromount-G (Southern Biotech) on slides and 
images were captured using a 63x oil objective on a Zeiss Observer Z1 microscope equipped with Axiovision Rel 
4.8 software. The percentage of cells with indicated foci was counted from three replicate experiments with at least 
50 cells counted per replicate. Unless specified otherwise γH2AX induction was used as control for damaged cells 
and cells containing greater than five foci were counted. 
 
Clonogenic Assay 
U2OS or MCF-7 cells were plated at a density of 3x102 cells/well in 6 well plates 24 hours after siRNA 
knockdown. Plating efficiency following siRNA knockdown was greater than 95%. Cells were allowed to adhere for 
24 hours after plating, and then drug treated or irradiated at doses as indicated. Cell media was changed 24 hours 
post-irradiation or drug treatment, and every 5 days thereafter. Cells were allowed to proliferate and methanol fixed 
and stained with crystal violet reagent after 10-14 days.  Colonies containing greater than 50 cells were manually 
counted and total numbers of cells at each radiation dose were normalized to non-treated control. 
 
DSB Repair Reporter Assay 
To determine HR-mediated DSB repair efficiency cells U2OS stably expressing DR-GFP reporter gene, 
described previously (Pierce et al., 1999), were transfected with 30 nM siRNA using Liptofectamine RNAiMax 
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(Invitrogen). The following day, media was changed and cells were transfected with plasmids (I-SceI and RFP). 
72hrs post plasmid transfection, cells were harvested and fixed in 1% PFA for FACS analysis. Cells expressing RFP 
were gated and analyzed for HR efficiency based on GFP expression. For rescue assays, I-SceI was co-transfected 
with RFP or SAMHD1-RFP (WT or HD/AA). To determine NHEJ-mediated DSB repair efficiency, we utilized a 
reporter gene based assay previously described (Seluanov et al., 2004). Briefly, pEGFP-Pem1-Ad2 was digested 
with I-SceI and gel purified to ensure the homogeneity of digested population. U2OS cells were transfected with 
non-targeting and two independent SAMHD1 siRNA while one group was treated with NU7206, a DNA-PKcs 
inhibitor. The next day, media was changed and cells were transfected with I-SceI digested pEGFP-Pem1-Ad2. 
DNA-PKCs inhibitor was kept on throughout the experiment. Cells were harvested and fixed in 1% PFA for GFP 
expression analysis by FACS. For the rescue assay, RFP positive cells were gated and analyzed for HR efficiency 
using GFP expression as readout. 
 
Laser Microirradiation Assay 
U2OS SAMHD1 WT or KO cells were transfected with GFP-RPA70, GFP-CtIP, GFP-MRE11, or 
SAMHD1-GFP/RFP WT or K484T.  15 hours post transfection, media was changed and cells were left to grow or 
plated for siRNA transfection. For SAMHD1 depletion induced impairment of RPA70 or CtIP, cells were 
transfected with indicated siRNA 24 hours post plasmid transfection. 48 hours post siRNA transfection, cells were 
plated on 35-mm glass bottom dishes (MatTek Corporation) for laser microirradiation. Laser microirradiation was 
performed on a Zeiss Observer Z1 microscope equipped with a Micropoint® Laser Illumination and Ablation 
System (Photonic Instruments). The laser output was set to 80 %, which can reproducibly give a focused GFP-
RPA70 stripes. The GFP or RFP stripes were recorded at indicated time points and then analyzed with 
ImageStudiolite. For assays involving endogenous proteins, localization to laser site was analyzed by subjecting 
cells to microirradiation, fixed in 4% PFA and visualized as indicated under the immunofluorescence assay 
described above.  
 
DNA End Resection  
To determine DNA end resection, U2OS, BEAS-2B, or small airway epithelial cells depleted of SAMHD1 
using two independent siRNA or U2OS SAMHD1 WT and KO cells were treated with CPT for 4 hours, 72 hours 
post transfection. Then cells were fixed in 4% PFA and analyzed for H2AX and RPA70 foci. For BrdU foci 
dependent DNA end resection analysis, cells were depleted of SAMHD1 and incubated with 30 µM BrdU for 36 
hours and then treated with 3 µM CPT for 4 hours. Then cells were fixed following pre-extraction. Briefly, cells 
were washed with cytoskeleton buffer (CSK) (10 mM PIPES, 300 mM Sucrose, 100 mM NaCl, 3 mM MgCl2, 1mM 
EGTA) and incubated in extraction buffer (0.5% Triton X100 in CSK buffer) at room temperature on a rocker for 15 
min. Then cells were washed with PBS, fixed and processed as described in the immunofluorescence assay section.  
For both RPA70 and BrdU foci based assays, fifty cells possessing H2AX foci were counted three times 
independently and RPA or BrdU foci was compared between SAMHD1 depleted and non-depleted cells. 
 
Comet Assay 
U2OS cells were depleted of SAMHD1 or CtIP using siRNA as described above. 48 hours post-
transfection and following 20 hours incubation with 500 M mimosine, cells were released for 7 hours and 
embedded in 0.5% low melting point agarose (Lonza) on individual slides. Then some of the slides were exposed to 
10 Gy IR and then incubated in complete media to allow for repair. At the indicated time, the cells were lysed for 2 
hours in 10 mM Tris, pH 10, 2.5M NaCl, 10 mM EDTA, 1% Triton X-100 and 10% DMSO at 4ºC. Lysis buffer was 
exchanged for TBE (220 mM Tris, 180 mM Borate, 5 mM EDTA pH 8.3) with three 10 minutes incubations. 
Electrophoresis was conducted at 20V for 30 min in TBE and cells were stained with sybr green (Invitrogen).  At 
least ten fields per slide where photographed at random by direct fluorescence microscopy using an Olympus IX81 
epifluorescence microscope. Fifty comets per slide were scored employing CometScore Software (TriTek). Dot plot 
graphs were generated with KaleidaGraph 4.5.2. Statistical analysis was performed using a Wilcoxon signed-rank 
test.  
 
Cellular dNTP Pool Quantification 
  
Cellular dNTP pool was measured as described previously (Lahouassa et al., 2012). Briefly, cells were 
depleted of SAMHD1 by transfecting with two different siRNAs or transfected with SAMHD1-GFP WT or K484T. 
72 hours post transfection, cells were washed with cold PBS and were lysed in 65% aqueous methanol. Lysates were 
heated to 95 °C, cleared by centrifugation, dried and resuspended in water. An 18-nucleotide primer labeled at the 5′ 
end with 32P was annealed to four different 19-nucleotide templates creating nucleotide variation at the 5′ end of the 
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template. The cell extracts were used as dNTP source to extend a single nucleotide at the 5’ end of the primer. 
Extended and unextended products were resolved on urea-PAGE and analyzed. The frequency of extended primers 
was determined with QuantityOne software. Dilutions required to obtain extension with in linear range was 
determined for each sample and used to perform the assay.  
 
Knock Out cells Generation 
The guide RNA (gRNA) sequences cloned in to All-in-one Cas9 and gRNA expression plasmid were 
purchased from Sigma. Two unique gRNAs targeting the 4th (gRNA1 CCTCGTCCGAATCATTGATACA) or 6th 
exon (gRNA2 TGCTCGCCCGGAGGTGAAATGG.) of SAMHD1 were selected in consultation with Sigma. HCT-
116 and U2OS cells were transfected with all-in-one plasmid expressing cas9, SAMHD1-targeting gRNA, and GFP. 
48 hours post-transfection, GFP-positive cells were sorted and plated and seeded in 96-well plates, one cell per well. 
Cells were grown for three weeks and analyzed for SAMHD1 expression as compared to WT and two colonies 
exhibiting SAMHD1 knockout were used for analysis. 
 
Chromatin Fractionation Assay  
HCT-116 cells were treated with 10 Gy IR and harvested after 1 hour recovery. Cells were trypsinized, 
washed with ice-cold PBS and fractionated as described previously (Mendez and Stillman, 2000). Briefly cells were 
lysed in buffer A (10mM HEPES, 10mM KCL, 1.5mM MgCl2, 0.34 M sucrose, 10% Glycerol, 1mM DTT and 
protease inhibitors) and incubated on ice for 5 minutes. The lysate was centrifuged and the pellet was washed with 
Buffer B (3mM EDTA, 0.2 mM EGTA, 1mM DTT and protease inhibitors). The lysate was then resuspended in 
50% Buffer A/ B, boiled in presence of SDS, and sonicated. The samples were resolved on SDS-PAGE and 
visualized with the Licor Odyssey system.    
 
Super Resolution Imaging 
U2OS cells (ATCC HTB-96) were grown in McCoy’s 5A (Modified) medium (ThermoFisher 16600) with 
10% FBS (Gemini Bio. 100-106) and 100 U/mL Penicillin-Streptomycin (ThermoFisher 15140). Cells were seeded 
on glass coverslips for 24 hours prior to 72 hours culture in FBS free medium to achieve a G0/G1 phase 
synchronization. Release back into full medium for 16 hours produced a mid-S phase cell population. To induce 
one-sided DSBs cells were treated with 100 nM CPT (Abcam 120115) for 1 hour. Simultaneously, naDNA was 
pulse-labeled with 10 M EdU (Click-iT kit, ThermoFisher C10340). Cells were allowed to recover from CPT 
damage for a further hour prior to pre-extraction in room temperature CSK buffer (10 mM Hepes, 300 mM Sucrose, 
100 mM NaCl, 3 mM MgCl2, and 0.5% Triton X-100, pH = 7.4) for 2-3 minutes followed by fixation for 15 minutes 
in paraformaldehyde (3.7% from 32% EM grade, Electron Microscopy Sciences, 15714) and glutaraldehyde (0.3% 
from 70% EM grade, Sigma-Aldrich, G7776) in PBS. For Alexa Fluor 647 fluorescent labeling of the nascent DNA, 
the copper catalyzed ‘Click’ reaction was used as described in the Click-iT protocol (ThermoFisher, C10640). The 
cells were blocked with blocking buffer (2% glycine, 2% BSA, 0.2% gelatin, and 50 mM NH4Cl in PBS) for 1 hour 
at room temperature (RT) and then immunostained in for SAMHD1 (mouse monoclonal, Origene TA502024) and 
CtIP (rabbit polyclonal, Santa Cruz, sc22838) with Alexa Fluors 568 and 488 secondary antibodies (Life Science). 
Prior to imaging, coverslips were mounted in SR buffer containing 1 mg/mL glucose oxidase 
(SigmaAldrich, G2133), 0.02 mg/mL catalase (SigmaAldrich, C3155), 10% glucose (SigmaAldrich, G8270)) and 
100 mM mercaptoethylamine (Fisher Scientific, BP2664100) in PBS. S-phase cells were then identified by strong 
EdU signal and imaged sequentially for three-color detection using a custom-built SR microscope based on a Leica 
DMI 3000 inverted microscope. Briefly, 488 nm (Coherent, 87-461, 150 mW), 556 nm (UltraLasers, MGL-FN-556 
200 mW) and 640 nm (OEM Laser Systems, MLL-III 150 mW) laser lines were combined using appropriate 
dichroics and focused onto the back aperture of a HCX PL APO 60X NA = 1.47 TIRF (Leica) objective via a multi-
band dichroic (Chroma, UF1C165837). For each area of interest 2000 sequential frames of single molecule 
emissions at 40 Hz were collected through the same objective and dichroic and imaged on a Prime 75B CMOS 
camera (Photometrics) using MicroManager.  
Each raw image stack was processed for single molecule localization and rendered using 20 nm pixels via 
rapidSTORM. These images were then mapped to correct for chromatic aberrations using Tetraspecks (beads were 
acquired across all three colors (Tetraspecks, 100 nm) as a reference sample and an elastic transformation generated 
using bUnwarpJ in FIJI. To determine the degree of colocalization in the resulting, thresholded (Otzu) three-color 
images, Monte Carlo simulations were used to randomly rearrange the clusters within an ROI to calculate a baseline 
level of random colocalization. Using this approach, 20 random simulations were generated for each nucleus in a 
pair-wise fashion, examining Red/Green, Red/Blue, and Green/Blue overlap. The total number of overlaps detected 
in each nucleus (typically 15-100) could then be normalized to the determined random level of overlap by dividing 
the number of real overlaps by the average number of overlaps in the same randomly-simulated nucleus. We display 
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these values as the normalized colocalization level above random where random overlap has a value of 1. For 
display purposes, images were smoothed by applying a Gaussian blur filter and colors were thresholded to best 
produce a clear picture of the single foci.   
Experiments were carried out in triplicate with between 10 and 25 nuclei imaged for each sample. Nuclei 
were excluded based on poor image quality (non-S-phase, aggregated fluorophores) or very low numbers of clusters 
in any color (<10). Between 31 and 75 nuclei were used to generate the data. A student's t-test was used to test for 
significance of difference between means of control and damaged samples with ** denoting p<0.01 and **** 
denoting p<0.0001.  
 
Statistical Analysis 
Unless otherwise stated, all experiments were performed at least three times. Results were analyzed using 
unpaired two-tailed Student’s t test and data expressed as mean ± SEM. p values less than 0.05 were considered 
statistically significant. 
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